These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 5696003

  • 1. [Beta-sympathicolytic effect of derivatives of prenylamine].
    Ehrhart G, Lindner E.
    Arzneimittelforschung; 1968 Mar; 18(3):291-5. PubMed ID: 5696003
    [No Abstract] [Full Text] [Related]

  • 2. [Studies on the mechanism of action of prenylamine].
    Lindner E.
    Arzneimittelforschung; 1969 Jan; 19(1):15-9. PubMed ID: 5819360
    [No Abstract] [Full Text] [Related]

  • 3. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H, Hedwall PR, Meier M.
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract] [Full Text] [Related]

  • 4. [Pharmacological and biochemical effects of hydralazine and dihydralazine].
    van Zwieten PA.
    Arzneimittelforschung; 1968 Jan; 18(1):79-84. PubMed ID: 4386976
    [No Abstract] [Full Text] [Related]

  • 5. Nutritional circulation in the heart. 3. Effect of isoproterenol and beta adrenergic blockade on myocardial hemodynamics and rubicium-86 extraction in the isolated supported heart preparation.
    Somani P, Laddu AR, Hardm HF.
    J Pharmacol Exp Ther; 1970 Dec; 175(3):577-92. PubMed ID: 4395225
    [No Abstract] [Full Text] [Related]

  • 6. [On the action mechanism of new coronary dilators with simultaneous oxygen saving myocardial effects, Prenylamine and Iproveratril. 1].
    Fleckenstein A, Kammermeier H, Döring HJ, Freund HJ.
    Z Kreislaufforsch; 1967 Jul; 56(7):716-44. PubMed ID: 5592004
    [No Abstract] [Full Text] [Related]

  • 7. [Selective inhibition of myocardial contractility by competitive divalent Ca++ antagonists (iproveratril, D 600, prenylamine)].
    Fleckenstein A, Tritthart H, Fleckenstein B, Herbst A, Grün G.
    Naunyn Schmiedebergs Arch Pharmakol; 1969 Jul; 264(3):227-8. PubMed ID: 4242380
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of beta-receptor blocking agents and related substances on the excitation, contraction and energy metabolism of myocardium fibers].
    Fleckenstein A, Döring HJ, Kammermeier H.
    Klin Wochenschr; 1968 Apr 01; 46(7):343-51. PubMed ID: 4386795
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of the beta-adrenergic blocking agentnethalide on some hemodynamic indices in experiment].
    Gorodinskaia VIa.
    Farmakol Toksikol; 1968 Apr 01; 31(1):15-8. PubMed ID: 4386335
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile.
    Charlier R, Deltour G, Baudine A, Chaillet F.
    Arzneimittelforschung; 1968 Nov 01; 18(11):1408-17. PubMed ID: 5755904
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of some beta-blocking agents on the effect of bradykinin on isolated guinea pig ileum].
    Bernardi M, Bertolini A, Castelli M.
    Boll Soc Ital Biol Sper; 1967 Oct 15; 43(19):1299-301. PubMed ID: 4385418
    [No Abstract] [Full Text] [Related]

  • 12. [Does prenylamine have beta-adrenolytic properties?].
    Boissier JR, Schmitt H, Giudicelli JF, Viars P.
    Therapie; 1968 Oct 15; 23(6):1371-81. PubMed ID: 5713558
    [No Abstract] [Full Text] [Related]

  • 13. [A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium].
    Fleckenstein A, Tritthart H, Flackenstein B, Herbst A, Grün G.
    Pflugers Arch; 1969 Oct 15; 307(2):R25. PubMed ID: 5814829
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of Verapamil on the metabolism of myocardium].
    Haas H, Gokel M.
    Arzneimittelforschung; 1970 May 15; 20(5):647-55. PubMed ID: 4393245
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and pharmacological study of diphenylalkylamines with cycloaliphatic residues. New coronary vasodilators.
    Carenini G, Carissimi M, Gentili PG, Grumelli E, Piccióla G, Ravenna F.
    Arzneimittelforschung; 1976 May 15; 26(12):2127-36. PubMed ID: 1037261
    [Abstract] [Full Text] [Related]

  • 16. The possible role of an adrenergic mechanism in the antianginal action of papaverine and prenylamine.
    Szekeres L, Papp JG, Fischer E.
    Eur J Pharmacol; 1967 Oct 15; 2(1):1-8. PubMed ID: 4384753
    [No Abstract] [Full Text] [Related]

  • 17. -Adrenergic blocking agents of the chromone and xanthone groups.
    Da Re P, Valenti P, Borraccini A, Primofiore GP.
    J Med Chem; 1972 Feb 15; 15(2):198-9. PubMed ID: 4400150
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of the cardioselective beta-receptor blocker (ICI 50172) on hemodynamics and oxygen consumption of the left ventricle in the dog (whole animal)].
    Bussmann WD, Krayenbühl HP.
    Helv Physiol Pharmacol Acta; 1968 Feb 15; 26(2):CR 199+. PubMed ID: 5723448
    [No Abstract] [Full Text] [Related]

  • 19. [The inherent contractility-reducing effect of various beta-adrenolytic agents on a heart-lung preparation in the dog].
    Schmidt HD, Schmier J.
    Z Kreislaufforsch; 1967 Nov 15; 56(11):1137-50. PubMed ID: 5595876
    [No Abstract] [Full Text] [Related]

  • 20. [Separation of the divalent Ca++ antagonistic effect component from the beta-adrenolytic effects of cardio-depressive drugs on cultures of embryonic heart muscle cells].
    Kaufmann R, Tritthart H, Rost B.
    Naunyn Schmiedebergs Arch Pharmakol; 1969 Nov 15; 264(3):252-3. PubMed ID: 4242400
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.